Mutation Occurrence in DNA Sequences of drug Resistance Plasmodium vivax in Iraqi patients Infection

2020 ◽  
Vol 13 (1) ◽  
pp. 339
Author(s):  
Ammer Abd. Mohammed
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Xiaoxiao Wang ◽  
Wei Ruan ◽  
Shuisen Zhou ◽  
Xinyu Feng ◽  
He Yan ◽  
...  

2020 ◽  
Vol 75 (7) ◽  
pp. 1766-1771 ◽  
Author(s):  
Camille Roesch ◽  
Mélissa Mairet-Khedim ◽  
Saorin Kim ◽  
Dysoley Lek ◽  
Jean Popovici ◽  
...  

Abstract Background Cambodia is the epicentre of the emergence of Plasmodium falciparum drug resistance. Much less is known regarding the drug susceptibility of the co-endemic Plasmodium vivax. Only in vitro drug assays can determine the parasite’s intrinsic susceptibility, but these are challenging to implement for P. vivax and rarely performed. Objectives To evaluate the evolution of Cambodian P. vivax susceptibility to antimalarial drugs and determine their association with putative markers of drug resistance. Methods In vitro response to three drugs used in the past decade in Cambodia was measured for 52 clinical isolates from Eastern Cambodia collected between 2015 and 2018 and the sequence and copy number variation of their pvmdr1 and pvcrt genes were analysed. pvmdr1 polymorphism was also determined for an additional 250 isolates collected in Eastern Cambodia between 2014 and 2019. Results Among the 52 cryopreserved isolates tested, all were susceptible to the three drugs, with overall median IC50s of 16.1 nM (IQR 11.4–22.3) chloroquine, 3.4 nM (IQR 2.1–5.0) mefloquine and 4.6 nM (IQR 2.7–7.0) piperaquine. A significant increase in chloroquine and piperaquine susceptibility was observed between 2015 and 2018, unrelated to polymorphisms in pvcrt and pvmdr1. Susceptibility to mefloquine was significantly lower in parasites with a single mutation in pvmdr1 compared with isolates with multiple mutations. The proportion of parasites with this single mutation genotype increased between 2014 and 2019. Conclusions P. vivax with decreased susceptibility to mefloquine is associated with the introduction of mefloquine-based treatment during 2017–18.


Acta Tropica ◽  
2020 ◽  
Vol 206 ◽  
pp. 105454
Author(s):  
Fei-Wen Cheong ◽  
Shairah Dzul ◽  
Mun-Yik Fong ◽  
Yee-Ling Lau ◽  
Sasheela Ponnampalavanar

2011 ◽  
Vol 10 (1) ◽  
pp. 282 ◽  
Author(s):  
Céline Barnadas ◽  
David Kent ◽  
Lincoln Timinao ◽  
Jonah Iga ◽  
Laurie R Gray ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Hugo O. Valdivia ◽  
Fredy E. Villena ◽  
Stephen E. Lizewski ◽  
Jorge Garcia ◽  
Jackeline Alger ◽  
...  

AbstractMalaria continues to be an important health problem in Honduras despite major progress achieved reducing its incidence in the last two decades. In a context of case reduction, continuing surveillance of parasite diversity and drug resistance is an important component to assist effective malaria control strategies and support risk assessments. In this study, we employed next generation sequencing on collected Plasmodium vivax and P. falciparum samples from the Hospital Escuela (University Hospital) in Honduras between 2005 and 2017. Hospital Escuela is the main public health hospital in Honduras and receives suspected malaria cases from endemic regions within the country. The resulting sequencing data was used to assess complexity of infections, parasite population structure, parasite diversity and drug resistance profiling. All P. vivax samples and all autochtonous P. falciparum samples were monoclonal and presented a low intra population diversity (π = 0.25 and 0.07, respectively). Genotyping of drug resistance markers showed that three P. falciparum samples presented the chloroquine resistant haplotype SVMNT on pfcrtr (positions 72–76). Epidemiological data suggested that two of these samples were imported cases from Africa whereas the third one was a local case. Three suspected imported cases (two of which were also pfcrt mutants) presented the pfmdr1 86Y mutation that further enhances the CQ resistant genotype. No evidence was found for kelch13 artemisinin resistance associated mutations nor parasite genetic background mutations. Discriminant analysis of principal components and phylogenetic analysis showed two P. vivax and two P. falciparum parasite sub-populations with limited recombination between them. It also confirmed the closer relationship of the three imported cases with African strains. Our findings showed that local Honduras P. falciparum strains do not hold CQ resistance polymorphisms which aligns with clinical data reported by the country and supports the continuity of CQ based treatment in Honduras. In addition, our findings highlight the need of using genomic approaches to provide key information about parasite biology including drug resistance, population structure and HRP2/HRP3 deletions which are becoming relevant as the country move towards elimination.


2016 ◽  
Vol 48 (8) ◽  
pp. 953-958 ◽  
Author(s):  
Daniel N Hupalo ◽  
Zunping Luo ◽  
Alexandre Melnikov ◽  
Patrick L Sutton ◽  
Peter Rogov ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Xingyi Jin ◽  
Sujuan Zhu ◽  
Weimin Xu ◽  
Junfang Chen ◽  
Wei Ruan ◽  
...  

Abstract Background Malaria causes major public health problems globally and drug resistance hinders its control and elimination. Molecular markers associated with drug resistance are considered as a beneficial tool to monitor the disease trends, evolution and distribution so as to help improve drug policy. Methods We collected 148 Plasmodium falciparum and 20 Plasmodium vivax isolates imported into Hangzhou city, China between 2014 and 2019. k13 gene of P. falciparum and k12 of P. vivax were sequenced. Polymorphisms and prevalence of k13 and k12 were analyzed. Results Most (98.65%, 146/148) P. falciparum infections were imported from Africa, and half P. vivax cases came from Africa and the other half from Asia. Nucleotide mutation prevalence was 2.03% (3/148) and the proportion of amino acid mutations was 0.68% (1/148). The amino acid mutation, A676S, was observed in an isolate from Nigeria. No mutation of k12 was observed from the parasites from African and Asian countries. Conclusions Limited polymorphism in k13 gene of P. falciparum isolates imported from African countries, but no evidence for the polymorphism of k12 in P. vivax samples from African and Asian countries was found. These results provide information for drug policy update in study region.


Sign in / Sign up

Export Citation Format

Share Document